Listen: Democratizing CRISPR, drugging the undruggable, and reading pharma’s fine print
In the latest episode of our #biotech #podcast, "The Readout LOUD," we cover a fascinating #CRISPR debate and one company's efforts to craft pills that can do what has thus…
by Damian Garde and Rebecca Robbins and Adam Feuerstein
Apr 18, 2019
1 minute
Who gets to “play God”? Can old technologies learn new tricks? And what does “drug price” even mean?
We discuss all
You’re reading a preview, subscribe to read more.
Start your free 30 days